Karyopharm Therapeutics (KPTI) to resume trading at 7:30 am

March 24, 2026 7:18 AM

Karyopharm Therapeutics (NASDAQ: KPTI) to resume trading at 7:30 am. Earlier:Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found